Septal gabaergic and hippocampal cholinergic systems interact in the modulation of anxiety

Neuroscience

Volumn 117, Issue 2, 2003, Pages 493-501

  Degroot, A ^a   Treit, D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Acetylcholine; Dorsal hippocampus; Medial septum; Neurotransmitters; Shock probe

Indexed keywords

MUSCIMOL; PHYSOSTIGMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; GABAERGIC SYSTEM; HIPPOCAMPUS; INFUSION; MALE; MODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SHOCK;

EID: 0037459818     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00651-6     Document Type: Article

References (59)

1. Allen C.N., Crawford I.L. GABAergic agents in the medial septal nucleus affect hippocampal theta rhythm and acetylcholine utilization. Brain Res. 322:1984;261-267.
2. Alonso A., K öhler C. A study of the reciprocal connections between the septum and the entorhinal area using anterograde and retrograde axonal transport methods in the rat brain. J Comp Neurol. 225:1984;327-343.
3. Amaral D.G., Witter M.P. Hippocampal formation. Paxinos G. The rat nervous system. 1995;443-493 Academic Press, San Diego.
4. Bhatnagar S., Costall B., Smythe J.W. Hippocampal cholinergic blockade enhances hypothalamic-pituitary-adrenal responses to stress. Brain Res. 766:1997;244-248.
5. Blampied N.M., Kirk R.C. Defensive burying effects of diazepam and oxprenolol measured in extinction. Life Sci. 33:1983;695-699.
6. Brioni J.D., Decker M.W., Gamboa L.P., Izquierdo I., McGaugh J.L. Muscimol injections in the medial septum impair spatial learning. Brain Res. 522:1990;227-234.
7. Carlton P.L. Brain acetylcholine and inhibition. Tapp J. Reinforcement and behaviour. 1969;286-327 Academic Press, New York.
8. Cheeta S., Kenny P.J., File S.E. Hippocampal and septal injections of nicotine and 8-OH-DPAT distinguish among different animal tests of anxiety. Prog Neuropsychopharmacol Biol Psychiatry. 24:2000;1053-1067.
9. De Boer S.F., Slangen J.L., Van der Gugten J. Plasma catecholamine and corticosterone levels during active and passive shock probe avoidance in rats effects of chlordiazepoxide. Pharmacol Biochem Behav. 47:1990;1089-1098.
10. Degroot A, Treit D (2002) Stimulating cholinergic receptors in the dorsal or ventral hippocampus modulates anxiety in the plus-maze and shock-probe tests. Brain Res, in press.
11. Degroot A., Parent M.B. Infusions of physostigmine into the hippocampus or the entorhinal cortex attenuate avoidance retention deficits produced by intra-septal infusions of the GABA agonist muscimol. Brain Res. 920:2001;10-18.
12. Degroot A., Kashluba S., Treit D. Septal GABAergic and hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests. Pharmacol Biochem Behav. 69:2001;391-399.
13. Degroot A., Parent M.B. Increasing acetylcholine levels in the hippocampus or the entorhinal cortex reverses the impairing effects of septal GABA receptor activation on spontaneous alternation. Learn Mem. 7:2000;293-302.
14. Drugan R.C., Skolnick P., Paul S.M., Crawley J.N. Low doses of muscimol produce anticonflict actions in the lateral septum of the rat. Neuropharmacology. 25:1986;203-205.
15. Durkin T. GABAergic mediation of indirect transsynaptic control over basal and spatial memory testing-induced activation of septo-hippocampal cholinergic activity in mice. Behav Brain Res. 50:1992;155-165.
16. Dutar P., Bassant M.H., Senut M.C., Lamour Y. The septohippocampal pathway structure and function of a central cholinergic system. Physiol Rev. 75:1995;393-427.
17. File S.E., Gonzalez L.E., Andrews N. Endogenous acetylcholine in the dorsal hippocampus reduces anxiety through actions on nicotinic and muscarinic receptors. Behav Neurosci. 112:1998;352-359.
18. File S.E., Kenny P.J., Ougazzal A.M. Bimodal modulation by nicotine of anxiety in the social interaction test role of the dorsal hippocampus. Behav Neurosci. 112:1998;1423-1429.
19. File S.E., Kenny P.J., Cheeta S. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol Biochem Behav. 66:2000;65-72.
20. Freund T.F., Antal M. GABA-containing neurons in the septum control inhibitory interneurons in the hippocampus. Nature. 336:1988;170-173.
21. Gray J.A. The neuropsychology of anxiety an enquiry into the function of the septo-hippocampal system. 1982;Oxford University Press, Oxford.
22. Gray J.A., McNaughton N. Comparison between the behavioural effects of septal and hippocampal lesions a review. Neurosci Biobehav Rev. 7:1983;119-188.
23. Gray J.A. Madden J. Neural systems, emotion and personality. 1991;273-306 Raven Press, New York.
24. Gray J.A., McNaughton N. The neuropsychology of anxiety. 2000;Oxford University Press, Oxford.
25. Hess C., Blozovski D. Hippocampal muscarinic cholinergic mediation of spontaneous alternation and fear in the developing rat. Behav Brain Res. 24:1987;203-214.
26. Kiss J., Patel A.J., Baimbridge K.G., Freund T.F. Topographical localization of neurons containing parvalbumin and choline acetyltransferase in the medial septum-diagonal band region of the rat. Neuroscience. 36:1990;61-72.
27. Menard J., Treit D. Does tolerance develop to the anxiolytic effects of septal lesions? Physiol Behav. 59:1996;311-318.
28. Menard J., Treit D. Lateral and medial septal lesions reduce anxiety in the plus maze and probe burying tests. Physiol Behav. 60:1996;845-853.
29. Menard J., Treit D. Effects of centrally administered anxiolytic compounds in animal models of anxiety. Neurosci Biobehav Rev. 23:1999;591-613.
30. Menard J., Treit D. Intra-septal infusions of excitatory amino acid receptor antagonists have differential effects in two animal models of anxiety. Behav Pharmacol. 11:2000;99-108.
31. Menard J., Treit D. The anxiolytic effects of intra-hippocampal midazolam are antagonized by intra-septal L-glutamate. Brain Res. 888:2001;163-166.
32. Naumann T., Linke R., Frotscher M. Fine structure of rat septo-hippocampal neurons I. Identification of septo-hippocampal projection neurons by retrograde tracing combined with electron microscopic immunocytochemistry and intracellular staining. J Comp Neurol. 325:1994;207-218.
33. Nauta W.J., Domesick V.B. Afferent and efferent relationships of the basal ganglia. Ciba Found Symp. 107:1984;3-29.
34. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic Press, New York.
35. Pesold C., Treit D. Excitotoxic lesions of the septum produce anxiolytic effects in the elevated plus-maze and shock-probe burying tests. Physiol Behav. 52:1992;37-47.
36. Pesold C., Treit D. The septum and the amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res. 638:1994;295-301.
37. Pesold C., Treit D. The neuroanatomical specificity of the anxiolytic effects of intra-septal infusions of midazolam. Brain Res. 710:1996;161-168.
38. Pinel J.P.J., Treit D. Burying as a defensive response in rats. Comp Physiol Psychol. 92:1978;708-712.
39. Risold P.Y., Swanson L.W. Connections of the rat lateral septal complex. Brain Res Brain Res Rev. 24:1997;115-195.
40. Rohmer J.G., Di Scala G., Sandner G. Behavioral analysis of the effects of benzodiazepine receptor ligands in the conditioned burying paradigm. Behav Brain Res. 38:1990;45-54.
41. Smythe J.W., Murphy D., Bhatnagar S., Timothy C., Costall B. The effects of intrahippocampal scopolamine infusions on anxiety in rats as measured by the black-white box test. Brain Res Bull. 45:1998;89-93.
42. Swanson L.W., Cowan W.M. An autoradiographic study of the organization of the efferent connections of the hippocampal formation in the rat. J Comp Neurol. 172:1977;49-84.
43. Toth K., Borhegyi Z., Freund T.F. Postsynaptic targets of GABAergic hippocampal neurons in the medial septum-diagonal band of Broca complex. J Neurosci. 13:1993;3712-3724.
44. Treit D., Pinel J.P.J., Fibiger H.C. Conditioned defensive burying a new paradigm for the study of anxiolytic agents. Pharmacol Biochem Behav. 15:1981;619-626.
45. Treit D. The inhibitory effects of diazepam on defensive burying anxiolytic vs. analgesic effects. Pharmacol Biochem Behav. 22:1985;47-52.
46. Treit D. Ro 15-1788, CGS 8216, picrotoxin, and pentylenetetrazol do they antagonize anxiolytic drug effects through an anxiogenic action? Brain Res Bull. 19:1987;401-405.
47. Treit D., Fundytus M. A comparison of buspirone and chlordiazepoxide in the shock-probe/burying test for anxiolytics. Pharmacol Biochem Behav. 30:1988;1071-1075.
48. Treit D. A comparison of anxiolytic and nonanxiolytic agents in the shock-probe burying test for anxiolytics. Pharmacol Biochem Behav. 36:1990;203-205.
49. Treit D., Pesold C. Septal lesions inhibit fear reactions in two animal models of anxiolytic drug action. Physiol Behav. 47:1990;365-371.
50. Treit D., Pesold C., Rotzinger S. Noninteractive effects of diazepam and amygdaloid lesions in two animal models of anxiety. Behav Neurosci. 107:1993;1099-1105.
51. Treit D., Pesold C., Rotzinger S. Dissociating the anti-fear effects of septal and amygdaloid lesions using two pharmacologically validated models of rat anxiety. Behav Neurosci. 107:1993;770-785.
52. Treit D., Menard J., Pesold C. The shock probe burying test. Neurosci Protoc. 3:1994;9-17.
53. Treit D., Menard J. Dissociations among the anxiolytic effects of septal, hippocampal, and amygdaloid lesions. Behav Neurosci. 111:1997;653-658.
54. Treit D., Menard J. The septum and anxiety. Numan R. The behavioral neuroscience of the septal region. 2000;210-233 Springer, New York.
55. Treit D, Degroot A, Shah A (2003) Animal models of anxiety and anxiolytic drug action. In: The handbook of depression and anxiety (den Boer JA, Ad Sitsen JM, eds), pp 681-702. Marcel Dekker, New York.
56. Trimble M.R. The neurology of anxiety. Postgrad Med J. 64:(suppl 2):1988;22-26.
57. Tsuda A., Yoshishige I., Tanaka M. The contrasting effects of diazepam and yohimbine on conditioned defensive burying in rats. Psychobiology. 16:1988;213-217.
58. Wainer B.H., Levey A.I., Rye D.B., Mesulam M.M., Mufson E.J. Cholinergic and noncholinergic septo-hippocampal pathways. Neurosci Lett. 54:1985;45-52.
59. Walass I., Fonnum F. Biochemical evidence for glutamate as a transmitter in hippocampal efferents to the basal forebrain and hypothalamus in the rat brain. Neuroscience. 5:1980;1691-1698.